All In Biotech

Free tool

FAERS Monitor: Furadantin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 009175 or its brand name (Furadantin, Nitrofurantoin). Reports on generic versions are filed under their own applications.

Reports

16,747

Serious

13,463

80% of reports

Hospitalization

5,733

Death reported

1,040

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • urinary tract infection1,399
  • fatigue1,291
  • nausea1,238
  • headache1,161
  • pain1,009
  • dyspnoea1,001
  • diarrhoea913
  • rash890
  • malaise866
  • vomiting854
  • pyrexia830
  • dizziness820
  • drug ineffective807
  • off label use753
  • fall608

Reports by year received

View as table
YearReports
200490
2005108
2006118
2007105
2008139
2009203
2010284
2011341
2012540
2013513
2014545
2015742
2016972
2017857
20181,200
20191,521
20201,343
20211,322
20221,282
20231,240
20241,152
20251,193
2026937

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,037,412 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
urinary tract infectionSignal1,39910.49.911,844
pyrexiaSignal8303.02.81,134
rashSignal8902.62.4866
malaiseSignal8662.52.3780
headacheSignal1,1612.32.2904
fallSignal6082.32.1450
vomitingSignal8542.32.1628
dyspnoeaSignal1,0012.22.1690
fatigueSignal1,2912.12.0754
dizzinessSignal8202.11.9460
painSignal1,0092.11.9569
nausea1,2382.01.9609
diarrhoea9131.81.7319
off label use7531.11.05
drug ineffective8070.80.760

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.